 |
|
Serum Homocysteine Concentration as an Indicator of Survival in Patients With Acute Coronary Syndromes
Torbjørn Omland, MD, PhD, MPH;
Anita Samuelsson;
Marianne Hartford, MD, PhD;
Johan Herlitz, MD, PhD;
Thomas Karlsson, MSc;
Benedicte Christensen, MD, PhD;
Kenneth Caidahl, MD, PhD
Arch Intern Med. 2000;160:1834-1840.
Background Circulating homocysteine levels are predictive of survival in patients with stable coronary artery disease. The prognostic value of serum homocysteine levels, obtained in the acute phase in patients with myocardial infarction or unstable angina, is unknown.
Objective To test the hypothesis that circulating homocysteine levels, obtained during the first 24 hours following hospital admission in patients with acute coronary syndromes, are predictive of long-term mortality.
Methods To test this hypothesis we performed a prospective inception cohort study at a teaching hospital in Gothenburg, Sweden. A total of 579 patients (179 women and 400 men; median age, 67 years) were included (Q-wave myocardial infarction in 163 patients, non– Q-wave myocardial infarction in 210 patients, unstable angina pectoris in 206 patients).
Main Outcome Measure All-cause mortality.
Results During a median follow-up of 628 days, 65 patients died. The serum homocysteine level (mean [SD]) was significantly lower in long-term survivors (n=514) than in nonsurvivors (n=65) (12.3 [7.0] vs 14.3 [5.9] µmol/L; P=.003). The relative risk (all-cause mortality) for patients with homocysteine levels in the upper quartile was 2.4 (95% confidence interval, 1.5-4.0) compared with that of patients in the 3 lower quartiles. After adjustment for relevant confounders, the relative risk estimate remained significant (relative risk=1.69; 95% confidence interval, 1.02-2.80). In a stepwise model the homocysteine level provided prognostic information additional to that of patient age, diabetes mellitus, and diuretic usage prior to hospital admission (P=.03).
Conclusion The serum homocysteine level on hospital admission is an independent predictor of long-term survival in patients with acute coronary syndromes.
From the Departments of Medicine (Dr Omland), and Medical Genetics (Dr Christensen), Ullevål University Hospital, Oslo, Norway; and the Departments of Cardiology (Drs Hartford and Herlitz and Mr Karlsson), and Clinical Physiology (Ms Samuelsson and Dr Caidahl), Sahlgrenska University Hospital, Gothenburg, Sweden.
RELATED ARTICLE
Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 2000;160(12):1879-1880.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Retinal Vein Occlusion, Homocysteine, and Methylene Tetrahydrofolate Reductase Genotype
McGimpsey et al.
IOVS 2005;46:4712-4716.
ABSTRACT
| FULL TEXT
Elevated Plasma Homocysteine Level Is an Independent Predictor of Coronary Heart Disease Events in Patients with Type 2 Diabetes Mellitus
Soinio et al.
ANN INTERN MED 2004;140:94-100.
ABSTRACT
| FULL TEXT
Association of Elevated Homocysteine Levels With a Higher Risk of Recurrent Coronary Events and Mortality in Patients With Acute Myocardial Infarction
Matetzky et al.
Arch Intern Med 2003;163:1933-1937.
ABSTRACT
| FULL TEXT
N-Terminal Pro-B-Type Natriuretic Peptide and Long-Term Mortality in Acute Coronary Syndromes
Omland et al.
Circulation 2002;106:2913-2918.
ABSTRACT
| FULL TEXT
Homocysteine Binds to Human Plasma Fibronectin and Inhibits Its Interaction With Fibrin
Majors et al.
Arterioscler. Thromb. Vasc. Bio. 2002;22:1354-1359.
ABSTRACT
| FULL TEXT
Preoperative Oral B Vitamins Prevent Nitrous Oxide-Induced Postoperative Plasma Homocysteine Increases
Badner et al.
Anesth. Analg. 2001;93:1507-1510.
ABSTRACT
| FULL TEXT
Multivitamin Supplements Are Effective and Inexpensive Agents to Lower Homocysteine Levels
Vos et al.
Arch Intern Med 2001;161:774-774.
FULL TEXT
Serum Homocysteine and Mortality in ACS Patients
Journal Watch Cardiology 2000;2000:8-8.
FULL TEXT
|
